Physician profile
Alaa Mansour
NPI 1902896608
$8,277.53
in general payments reported to CMS, 2019-2025
46 companies · $1,151 in 2025
The $1,151 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2020: $1,135 · 2021: $1,356 · 2022: $1,536 · 2023: $1,110 · 2024: $1,410 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,671.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,415.72 | 2019-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $1,054.66 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $816.84 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $645.48 | 2020-2025 | Airsupra, Breztri |
| Pfizer INC. | $628.22 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $369.28 | 2019-2024 | Jardiance |
| Glaxosmithkline, LLC. | $249.11 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Abbott Laboratories | $234.79 | 2021-2025 | Freestyle Libre 3 |
| Abbvie INC. | $222.14 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $216.54 | 2021-2022 | |
| Stryker Corporation | $173.48 | 2024 | Infinity, Ortholoc 3di |
| Phathom Pharmaceuticals, INC. | $163.49 | 2024 | Voquezna |
| Aroa Biosurgery Incorporated | $134.19 | 2024 | |
| Horizon Therapeutics Plc | $125.08 | 2021 | |
| Acumed LLC | $125.03 | 2023 | Acumed, Osteomed |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alaa Mansour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.